Urine hormone tests in people with heavy or irregular periods to study uterine cancer
Studies urine hormone levels in adults with abnormal uterine bleeding to track uterine cancer.
Plain-language title generated from the registry record
Registry title: Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression
Key facts
- Where
- Vancouver, CanadaSee the site
Where in Canada
- Vancouver General Hospital Research PavillionVancouver, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of British Columbia
- Trial code
- NCT07581288
- Record updated
- 12 May 2026
- Original description
The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.Read full original descriptionShow less
Quantitative Hormonal Biomarkers of Uterine Cancer Progression in Patients With Abnormal Uterine Bleeding
The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.
Inclusion: 35 years and older; Have experienced AUB.
Exclusion: Previous surgeries impairing the menstrual cycle (e.g. hysterectomy, bilateral oophorectomy); Currently or in the previous 3 months on medications that are known to impair or stimulate ovulation (e.g. oral contraceptives, ovulation stimulants, hormone replacement, etc.); Currently pregnant or become pregnant during their participation.